142nd APHA Annual Meeting and Exposition

Annual Meeting Recordings are now available for purchase

309512
Tobacco cessation practices and beliefs among clinicians in a public hospital system

142nd APHA Annual Meeting and Exposition (November 15 - November 19, 2014): http://www.apha.org/events-and-meetings/annual
Tuesday, November 18, 2014 : 12:50 PM - 1:10 PM

Michael D. Celestin Jr., MA, CHES, CTTS , School of Public Health, Louisiana State University Health Sciences Center, New Orleans, LA
Tung-Sung Tseng, DrPH., M.S. , School of Public Health, Louisiana State University Health Sciences Center - New Orleans, New Orleans, LA
Krysten Jones, MPH, CHES, CTTS , School of Public Health, Louisiana State University Health Sciences Center, Shreveport, LA
Sarah Moody-Thomas, PhD , School of Public Health, Louisiana State University Health Sciences Center, New Orleans, LA
Reductions in US tobacco use have stalled, allowing smoking to remain the leading preventable cause of illness and death among adults, especially low SES and uninsured populations. Health professionals, other than physicians, can greatly impact cessation treatment. However, further research is needed to understand their current practices and beliefs. This study examines practices and beliefs regarding smoking and cessation treatment by various clinicians in a safety-net health care delivery system. Data come from a cross-sectional electronic-survey administered to 2,519 clinicians (e.g. physicians, nurses) in Louisiana’s public hospital system (83% response rate) between April and June, 2012. Descriptive data on smoking, cessation practices and beliefs, along with multivariate regression analysis of factors associated with clinical practice guideline intervention, are presented. Overall, clinicians reported low smoking rates (3.76% - 9.76%), except for nurses (RNs = 12.71%, LPNs = 14.63%). Clinicians were more likely to Ask (90.97% - 100%) about tobacco use, Advise (75.96% - 96.57) smokers to quit, and Assess (69.57% - 91.71%) their readiness to quit, but less likely to Assist (26.09% - 67.66%) smokers with their quit attempt and Arrange (2.27% - 17.82%) follow-up contact. Compared to primary care physicians who performed all 5 A’s, those who didn’t were more likely to feel uncomfortable asking patients if they smoke, and less likely to agree that as a healthcare provider tobacco use is important to address. Nurses were less likely to complete any of the 5 A’s compared to primary care physicians. And, compared to Whites, Blacks were more likely to Assist, and Latinos more likely to Arrange. Use of the evidence-based treatment model decreases as clinicians progress along the 5 A’s continuum. This information will be used to develop strategies for clinician intervention to improve adherence to the guideline.

Learning Areas:

Administer health education strategies, interventions and programs
Implementation of health education strategies, interventions and programs
Planning of health education strategies, interventions, and programs
Provision of health care to the public
Public health or related research

Learning Objectives:
Compare differences in tobacco use, cessation practices and beliefs among various clinicians in a public hospital system. Discuss strategies to improve clinician adherence to the clinical practice guideline for treating tobacco use.

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I have worked in tobacco prevention and cessation for 15 years, the last 8 as an administrator in the LSU Health Sciences Center School of Public Health. Since 2005, I have worked on a state-wide Tobacco Control Initiative in Louisiana’s 10 facility public hospital system utilizing systems change strategies to integrate comprehensive tobacco cessation activities. I am certified as a Health Education Specialist through NCHEC and a Tobacco Treatment Specialist through the Florida Certification Board.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.